Real World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort

Condition:   Multiple Sclerosis, Relapsing-Remitting Intervention:   Drug: Natalizumab Injection [Tysabri] Sponsors:   University Hospital, Caen;   Biogen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials